Although much of the work carried out with xenografts has been directed towards assessing the responses of human tumours, particularly to the effects of cytotoxic drugs (e.g. Schold et al., 1989; Rofstad, 1990) , systems using normal human tissues provide opportunities to study effects of a variety of agents on human cells maintained and exposed under physiological conditions.
Normal human female breast samples taken from patients undergoing surgery for benign tumours can be transplanted successfully into the immunologically deficient athymic nude mouse and the ductal elements of these xenografts respond to mitogenic stimuli such as oestrogen and progesterone (McManus & Welsch, 1984; Laidlaw et al., in preparation) . However, when measurements of DNA labelling indices are made on fresh biopsy material the proliferative capacity is higher in the samples taken in the latter half of the menstrual cycle when circulating progesterone (rather than oestrogen) levels are highest (Potten et al., 1988) . Details of mechanisms leading to these proliferative responses or the effects of taking samples close to, or distal from breast lesions remain obscure (Potten et al., 1987) but when samples are dissected a distance from breast lesions to ensure normal tissue, xenografts established from these sources responded consistently to increased circulating levels of oestrogen and not to progesterone. In these studies a progressive 4-5-fold increase in the proliferative capacity of the ductal epithelium was observed in response to oestradiol (Laidlaw et al., in preparation) .
As current theories of human carcinogenesis implicate both carcinogen exposure and host responses (e.g. Pitot, 1990 ) the xenograft system potentially offers an experimental approach by which to test some of the observations made via epidemiological approaches and importantly to identify cells at risk within the tissue. Only limited progress has been made so far in this direction. For example, treatment of human skin xenografts with the direct acting benzo(a)pyrene diolepoxide I, an activated form of benzo(a)pyrene, led to the formation of higher levels of the major adduct N2-deoxyguanosine in the DNA of the epidermis than of the dermis. When the parent hydrocarbon was administered no Received 25 October 1991; and in revised form 2 March 1992. differences in adducts levels were detected. In this system, modification of the efficacy of reaction with DNA was observed when xenografts were pretreated with allantoin or anthralin and thereby increasing levels of both the major and minor DNA adducts (Yohn et al., 1988; . Kurian et al., 1989) .
In the present study, normal human female breast xenografts maintained with, or without, increased circulating levels of oestrogen have been exposed to the environmental nitrosamine, N-nitrosodimethylamine (NDMA). A nitrosamine was employed because these agents are ubiquitous in the human environment and NDMA is commonly found in such situations (Bartsch & Montesano, 1984) . NDMA may arise from both exogenous and endogenous sources as well as from the metabolism of certain drugs (Margison & O'Connor, 1990 ) and together with other environmental factors could be associated with the multifactorial aetiology of breast cancer.
Evidence now indicates that an interaction of exposures to environmental carcinogens and inherent tissue susceptibility combine to influence not only cancer incidence but also the biological behaviour of the neoplasms induced (Harnden, 1990) . Indeed, in breast tissue, exposure to environmental carcinogens and reproductive hormone-mediated tissue susceptibility are both implicated in breast cancer risk (Krieger, 1989) . In the following studies radioimmunoassays (Wild et al., 1983; O'Connor et al., 1988) have been used to detect the formation of adducts in the DNA of breast xenografts maintained in animals given NDMA. Immunohistochemical procedures (O'Connor et al., 1988; Fan et al., 1989 Fan et al., , 1990 have also been used to detect the promutagenic lesion o6-methylguanine in the DNA of cells of the breast acini. These observations indicate that environmental alkylating agents can act at the level of specific cells in breast tissue and that these could be targets for the deleterious and carcinogenic effects of these agents (Saffhill et al., 1985; Margison & O'Connor, 1990 17P-Oestradiol was mixed with Salistic emulsion (1:12.5; w/w) to prepare slow-release pellets that were placed under the dorsal skin close to the base of the tail to provide a serum oestradiol concentration of 1000-2000 pmoles 1( human luteal phase physiological levels; Gannong, 1985) for 7 days prior to carcinogen treatment. This is at least an order of magnitude higher than the endogenous mouse hormone level which could not readily be detected by radioimmunoassay.
NMU was taken up in a minimal amount of dimethylsulphoxide for dispersion in saline and NDMA was diluted in normal saline; both were administered intraperitoneally as indicated in the text between 10.30 am-12.00 noon. Two animals, one with and one without oestrogen treatment, were given NMU (100 mg kg-') and killed after 2 h. NDMA (10 mg kg-1) was given to four mice, two with and two without oestrogen treatment which were killed after 4 h. Tissues from these animals were fixed in 70% ethanol and used for immunohistochemistry (IHC) . Subsequently, two groups of 12 and eight mice, both maintained on oestrogen, were given NDMA 10 mg kg-' or 20 mg kg-' respectively.
Xenografts from these animals were frozen in liquid nitrogen and stored at -70°C for DNA isolation, except for one xenograft from each mouse which was fixed in 70% ethanol for IHC. As a preliminary to these experiments, nude mice and BDF1 (C57B1/6J x DBA2) mice were given NDMA at 5, 10 and 20 mg kg-' (i.p.); after 4 h liver, kidney and lung were removed for DNA preparation and for ethanol fixation (as above).
DNA preparation and radioimmunoassays In order to loosen the dense connective tissue, xenografts were first incubated with hyaluronidase (0.1%, w/v) and collagenase (0.05%; w/v) in PBS containing 5 mM CaC12 for 1 h at 37°C. Grafts were then homogenised and DNA was prepared by the phenol method (Kirby & Cook, 1967) . DNA was digested enzymically and separated by Aminex A7 chromatography. Amounts of 06-MedG eluted from the column were estimated by radioimmunoassay (three separate determinations) using a monoclonal antibody to 06-MedG and amounts of the common purine deoxynucleosides were measured by spectrophotometry. Details of these procedures were given earlier (Wild et al., 1983; Saffhill et al., 1988; O'Connor et al., 1988) .
Immunohistochemical procedures Overnight, ethonol-fixed tissues were embedded in paraffin and sectioned at 3 ytm. After dewaxing and rehydration, sections were treated with 70 mM NaOH for 30 s to denature the DNA and exposed overnight at 4°C to the primary antibody (rabbit anti-O6-methyl-2'-deoxyguanosine; Wild et al., 1983; Saffhill et al., 1988; O'Connor et al., 1988) (Wild et al., 1983) ; (ii) it binds only weakly to control, unalkylated DNA ; (iii) (Fan et al., 1989) and (v) nuclei in control sections from animals not given an alkylating agent are negative but some background staining occurs in the cytoplasm, as also occurs in sections from animals treated with alkylating agents (Fan et al., 1989 (Fan et al., , 1990 . The following test procedures were carried out using xenografts and liver from the same animals given NDMA and, rat stomach from animals given N-methyl-N'-nitro-N-nitrosoguanidine as a further control on which extensive IHC experience had been gained . Nuclei of the nitrosamine exposed tissues were negatively stained when (i) the primary antibody was replaced with 12.5% bovine serum albumen, an equivalent dilution of normal rat serum or, primary antibody preadsorbed with o6-methyl-2'-deoxyguanosine; (ii) the sodium hydroxide denaturation step and/or the primary antibody exposure was omitted from the procedure and (iii) a pancreatic DNase I incubation was included prior to exposure to the primary antibody. Nuclei remained positively stained for 06-MedG when (i) sections were pre-incubated with yeast RNase (but not when DNase I was included at this stage); (ii) sections were pre-adsorbed with NGS before exposure to the primary antibody and (iii) when 0.5% Triton X-100 was included in the PBS washes. The latter had no effect on nuclear staining but slightly reduced the background cytoplasmic staining. Amounts of 00-MedG in DNA of xenografts Figure 1 shows the formation of 06-MedG in xenograft DNA in the range 5-34tLmolesmoles-' dG following treatment with NDMA, indicating that the nitrosamine had been metabolised to an active form by the cells of the xenograft tissue. The 06-MedG level increased with the dose of NDMA but was not directly proportional to the dose.
Immunohistochemical localisation of methylated cells Nuclei staining positively for 06-MedG were present in cells of the glands, supportive fibrous tissue and adipose tissues in decreasing order of prevalence (Figure 2) . Staining was, however, heterogeneous. For example among the glands, staining varied from all cells being positively stained to a few cells positively stained, whilst a few of the glands were completely negative. Heterogeneity was also observed between the various xenografts and -10-15% of these contained no methylated cells at either dose. The presence of positive staining for 06-MedG indicated that some cells, particularly those of the glandular epithelium (see Figure 2) , were capable of activating NDMA and thereby becoming potential targets for the action of the nitrosamine. Some mouse fibroblasts at the periphery of the dissected xenografts also had nuclei stained positively for 06-MedG.
Cellularity of xenografts Sections were also stained with the fluorescent dye Hoechst 33258 in order to identify cells of murine or human origin (Figure 3 ). Murine cells, identified by the presence of several small intensely fluorescent intranuclear bodies (Cunha & Vanderslice, 1984) , were relatively few in number and were present mainly at the outer extremities of the graft, with very few invading the tissue of the graft itself. Overall, murine cells represented no more than 5-10% of the cells in sections of the grafts. The majority of the cells in the xenografts had more or less homogeneous staining across the nuclei (i.e. were of human type). Almost all of the cells of the glandular tissue had nuclei with human staining characteristics. It was evident that the majority of the cells in the dissected xenografts were of human origin and that murine cells had not invaded the regions containing viable acini.
Discussion
Preliminary experiments indicated that the nude mouse was no more susceptible to NDMA toxicity than normal mice and therefore could be used to study the effects of NDMA over a range of doses (Zaidi & O'Connor, in 
preparation ).
When the direct acting agent NMU was administered to graft bearing animals and the grafts were examined immunohistochemically, the nuclei of all the cells contained 06-MedG indicating that the agent was distributed freely throughout the graft and could interact with nuclear DNA. The effects of NDMA were then examined in the presence or absence of an oestrogen release-pellet. When higher circulating levels of oestrogen were present, the increased frequency and staining intensity of the graft cell nuclei suggested that the presence of 17p-oestradiol had increased the extent to which NDMA is metabolised to its active intermediate and for this reason subsequent experiments were carried out in animals given oestrogen release-pellets.
In animals with oestrogen implants and then given NDMA (10 or 20 mg mg'), the extent of formation of 06-MedG in DNA, as measured by RIA, although dose related, was not directly proportional to dose (Figure 1) . The disproportionately low level at the lower dose might be due to interindividual variations in the metabolism of NDMA but as 12 animals, each with 8 grafts were used, this seems an unlikely possibility. It is more likely to be explained either by a DNA repair process or to a detoxification mechanism which is efficient at low doses. An 06-methylguanine-DNA alkyltransferase (ATase) protein has been detected in human breast tissue at levels of 221 ± 2.1 (SEM) fmol per mg protein or 10.07 ± 0.98 (SEM) fmol per ;tg DNA; although there were large individual variations in activity no differences were found between samples of neoplastic and non-neoplastic origin (Cao et al., 1991) . As repair by this protein occurs by Figure 3 Fluorescence microscopy of a section of a human breast xenograft maintained in a nude mouse given Nnitrosodimethylamine (20 mg kg-') 4 h before sampling. This was stained using Hoecht 33258 to demonstrate nuclear chromatin; low power view of the outer edge of a section of a single graft showing an acinius, (a); high power view of the nuclei of the same acinus cut in transverse section, (b) ; and of mouse cell nuclei from the periphery of the graft, (c); the arrows indicate nuclei in sharp focus to show the intensely fluorescent bodies of the murine nucleus. These differences between cells of murine and human origin are more readily observed by adjusting up and down through the plane of focus (see text).
an auto-inactivating process (Saffhill et al., 1985) a limitation in the numbers of molecules of ATase would limit the depletion of 06-MedG adducts in DNA, thereby saturating the repair process at higher doses of NDMA but not at the lower doses. From these studies, however, it is not possible to determine which cell types (see below) might be responsible (Fan et al., 1990) , aflatoxin B, (Wild et al., 1990) and N-nitroso-bis(2-oxopropyl)-amine (Bax et al., 1991) . Whilst 06-MedG positive nuclei were found in all cell types i.e. cells of the acini, myoepithelium, fibrous tissue, adipose cells and residual mouse cells, most prominent were the cells of the glandular epithelium (Figure 2 ). An examination of the cellularity of these xenografts showed that the cells of murine origin were restricted essentially to the edges of the graft and constituted no more than 5-10% of the cells in the dissected graft (Figure 3 ). Figure 1 are attributable to reactions with all cell types (see above), including the cells of murine origin, it is evident that the breast epithelial cells account for at least a significant part of this.
The localisation of promutagenic DNA damage in cells of breast tissue which are the putative targets for breast carcinogenesis has the following implications: Firstly, these xenografts appear to respond to oestrogen, not only by apparently increasing the capacity for NDMA metabolism but also by increasing the rate of DNA synthesis and cell division (Laidlaw et al., in preparation) . The system therefore has the capacity for initiation by the induction of chemical mutations i.e. GC-*AT transitions arising from the replication of DNA templates containing 06-MedG (Saflhill et al., 1985) . As oestrogens are also deemed to act as promotors of carcinogenesis in breast tissue (Howell, 1989) it is possible that grafts maintained and treated in this way may provide a model system for human breast carcinogenesis, at least for the earliest stages of development. Secondly, they also provide an opportunity to test rigorously the apparent ability of oestrogens such as 17p-oestradiol to increase the capacity of breast tissue for the metabolism of environmental carcinogens such as NDMA. A detailed study of this process and the extent of individual variability may contribute towards an understanding of risk prediction.
Although the properties exhibited by these grafts may be attenuated to a degree in relation to those present in vivo they nevertheless provide important indications for mechanisms in breast carcinogenesis and for future investigations.
